Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Long-Term Debt : $49,487.00 Mil (As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Bristol-Myers Squibb Co Long-Term Debt?

Bristol-Myers Squibb Co's Long-Term Debt for the quarter that ended in Mar. 2024 was $49,487.00 Mil.

Bristol-Myers Squibb Co's quarterly Long-Term Debt increased from Sep. 2023 ($32,137.00 Mil) to Dec. 2023 ($36,653.00 Mil) and increased from Dec. 2023 ($36,653.00 Mil) to Mar. 2024 ($49,487.00 Mil).

Bristol-Myers Squibb Co's annual Long-Term Debt declined from Dec. 2021 ($39,605.00 Mil) to Dec. 2022 ($35,056.00 Mil) but then increased from Dec. 2022 ($35,056.00 Mil) to Dec. 2023 ($36,653.00 Mil).

Bristol-Myers Squibb Co Long-Term Debt Historical Data

The historical data trend for Bristol-Myers Squibb Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Long-Term Debt Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

43,387.00

48,336.00

39,605.00

35,056.00

36,653.00

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															35,078.00	34,656.00	32,137.00	36,653.00	49,487.00

Bristol-Myers Squibb Co (NYSE:BMY.R) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Bristol-Myers Squibb Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (NYSE:BMY.R) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.